Company Filing History:
Years Active: 1997-1999
Title: Wolfgang Schonfeld: Innovator in Pharmaceutical Chemistry
Introduction
Wolfgang Schonfeld is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of amino acid derivatives. With a total of 2 patents, his work focuses on improving the tolerability and efficacy of pharmaceutical compounds.
Latest Patents
Wolfgang's latest patents include innovative formulations that enhance the tolerability of pharmaceutically active β-amino acids. The first patent relates to mixtures of α-amino acids and cyclopentane-β-amino acids, which demonstrate improved tolerability in warm-blooded animals compared to pure cyclopentane-β-amino acids. The second patent involves cyclopentane-β-amino acid tripeptides, detailing their preparation and use as antimicrobial medicaments, particularly against fungal infections.
Career Highlights
Wolfgang Schonfeld is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical company. His work at Bayer has allowed him to explore and develop new pharmaceutical compounds that address critical health challenges. His innovative approach has positioned him as a key figure in the field of pharmaceutical research.
Collaborations
Throughout his career, Wolfgang has collaborated with esteemed colleagues, including Michael Matzke and Hans-Christian Militzer. These collaborations have fostered a productive environment for research and innovation, leading to advancements in pharmaceutical applications.
Conclusion
Wolfgang Schonfeld's contributions to pharmaceutical chemistry through his patents and collaborations highlight his commitment to improving health outcomes. His innovative work continues to influence the development of effective medicinal compounds.